Short Interest in International Stem Cell Co. (OTCMKTS:ISCO) Expands By 400.0%

International Stem Cell Co. (OTCMKTS:ISCO) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,500 shares, an increase of 400.0% from the December 31st total of 300 shares. Based on an average daily volume of 22,400 shares, the short-interest ratio is presently 0.1 days.

International Stem Cell Trading Up 16.7 %

ISCO stock opened at $0.11 on Wednesday. The business’s fifty day simple moving average is $0.10 and its two-hundred day simple moving average is $0.08. International Stem Cell has a twelve month low of $0.05 and a twelve month high of $0.20.

About International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.